DNA Modifying Enzymes Market
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP32370
DNA ligases and Restriction enzymes characterize the cutting and joining purposes in the manipulation of DNA. All further enzymes tangled in genetic engineering comes under the wide class of enzymes known as DNA modifying enzymes. DNA modifying enzymes are commonly used for the synthesis, degradation, and modification of nucleic acids. Modifying enzymes modify the DNA by either adding or removing a chemical group. The three most common groups are alkaline phosphatase, polynucleotide kinase and terminal transferase. Enzymes that modify DNA are useful because they allow the investigator to manipulate DNA in defined ways. DNA modifying enzymes are of various types such as nucleases, polymerases including DNA Polymerase I, Terminal transferase (TdT), DNA ligase, ligases, T4 RNA ligase and T4 DNA ligase.
Developments in automation to advance production competence have improved machinery and equipment costs. The early investment in equipment & machinery for enzymes is huge owing to the long process involved. The increasing demand for reduced sustainability, the possibility of infection, user-friendliness, clean & hygienic machinery and decreased handling costs, may have a positive impact on the price trend. However, this, in turn, will help the company gain a competitive edge over the other industry participants and support the market growth over the forecast period.
Nucleases & Polymerases have been boosting the biotechnological advancements for research & developments in various industries. They have been used for molecular cloning for nucleic acids manipulation to produce advanced enzymes available for viable uses. Nucleases and Polymerases have been greatly used in the pharmaceutical and biotechnological industry. The manufacturer is investing in biotechnological innovations to produce various types of drugs. Furthermore, their usage encourages speedy expansions of new diagnostic tests that used to target RNA and DNA substrates.
DNA Modifying Enzymes have extended a significant market share in the current years, owing to the high adoption of DNA Modifying enzymes centered pharmaceuticals required for the treatment of numerous chronic disorders, rare disease and digestive diseases. Developments in the pharmaceutical and biotechnology field such as the introduction of protein and genetic engineering have directed to broadening of applications of modifying enzymes, which is further fueled the growth of the market. Moreover, expansion in healthcare structure and extraordinary demand for improved healthcare facilities in developing markets is expected to boost the market growth in the coming years.
The growing need for DNA modifying enzymes in several industries along with the widespread use of genetic engineering is the key factor boosting the growth of the global DNA modifying enzymes market.
Various factors such as the adherence to the international regulations executed by different governing agencies are hampering the growth of the DNA Modifying enzymes market. Moreover, the lack of standardization in the regulatory structure for the industrial use of DNA modifying enzymes hinders the growth of this market.
Based on product type, the global DNA modifying enzymes market has been segmented as
Based on applications, the global DNA modifying enzymes market has been segmented as
Based on end-users, the global DNA modifying enzymes market has been segmented as
Based on the region, the global DNA modifying enzymes market has been segmented as
Increasing investments in the research and biotechnology sector for the development of new therapeutic and diagnostic solutions is the key factors driving the global DNA modifying enzymes market. Growing demand for therapeutics, strong funding enterprises, and broad research activities are anticipated to drive this sector, which, in turn, is expected to supplement the product sales in the next few years. R&D centers of several companies are focusing on development, upscaling, evaluation, validation of technologies, and innovative modifying enzyme formulation for commercial processing as well as human well-being. These research centers have developed expertise in the cloning and expression of DNA modifying enzymes in suitable microbial hosts.
The important applications in the pharmaceutical sector include killing disease-causing microorganisms, diagnosing diseases and promoting wound healing. Increasing consumer demand, population, and awareness about disorders and their consequences are projected to increase the utilization of these products in the pharmaceutical industry. Growing research and development has made it possible for speciality enzymes to be used in drug formulation and delivery. Pharmaceutical and biotechnological Manufacturers are prone to the production of pharmaceutical drug formulations by using a DNA modifying enzyme that has lesser adverse effects.
DNA ligase is an enzyme that controls irregularities. It generates a break in the strong backbone of double-stranded DNA molecules in the process. It plays an important role in the process of DNA repair and DNA replication. DNA ligase is responsible for three common purposes: sealing recombination fragments, sealing repairs in the DNA, and connecting Okazaki fragments that are formed during the replication of double-stranded DNA in the cell. DNA ligase has the role of creating a bond between the end of an ‘acceptor’ nucleotide and at the end of a ‘donor’ nucleotide. It is used to modify the properties of food such as digestibility, nutritional content, taste, shelf life, and texture. Research activities for sequencing applications, increase in the prevalence of infectious diseases, increase in the birth rate, and increase in genetic disorders are major factors that are accountable for the popularity of DNA ligases in the DNA modifying enzyme market. Moreover, a increase in R&D to develop ligases as therapeutic interferences for cancer and diseases is expected to drive the market.
Key players such as
The established manufacturers are exploring opportunities in developing nations like India, China to enhance their revenue gains by highly investing in research areas to innovate progressive solutions for DNA Modifying Enzymes Market.
The companies are actively focusing on the expansion of their product portfolio. The leading companies are actively participating in collaborative agreements and acquisitions to increase their DNA Modifying Enzymes Market penetration and shape their position in the leading DNA Modifying Enzymes Market. Additionally, the companies are actively entering into strategic distribution agreements to expand their sales footprint worldwide
For instance, On February 16, 2018, Lucigen Corporation acquired LGC, to the consolidation of its reagents offering to increase LGC’s exposure to the fast-growing NGS and gene editing markets.
The market has witnessed an increase in the need for superior quality speciality enzymes such as DNA modifying enzymes. As a result, suppliers and manufacturers have significant opportunities to deliver high-quality products and uniform products through a reviewed supply chain.
The enzymes market in the North American region is largely fueled by technological advancements that have made DNA modifying enzymes available for an extensive scope of applications. These advancements have contributed, specifically to the growth of the DNA modifying enzymes market in North America. Though the enzymes market in this region has reached its full growth, the pharmaceutical industry has observed an increase in the applications of DNA modifying enzymes.
U.S. is the leading In North America market, owing to the increase in the use of DNA modifying enzymes in pharmaceuticals, biotechnological and diagnostic applications. Besides, manufacturers in North America are focusing on intensifying the production capacity owing to rising demands from the local market. Furthermore, they are investing in new technologies to satisfy the growing needs of the bioenergy industry.
The outbreak of Covid-19 had hit the toughest areas in the low as well as in the developed region. The countrywide lockdown, disruption in the supply chain, restriction for migration, had fallen down the global economic market. The reduction in inpatient visits in hospitals and clinics to prevent the exposure of coronavirus infection and additional spending anticipated short term negative impact on the DNA Modifying Enzymes Market.
The sustainability of this market is majorly accredited to the extensively increasing demand in molecular biology, biofuels, bio-detergent, pulp and paper manufacturing processes, and rubber manufacturing. Owing to the pandemic, a large number of the companies which are functioning in the manufacturing of enzymes are currently working on the production of sanitisers to fight against COVID-19. For instance, in April 2020, BASF, the major enzyme manufacturer, has started the production of hand sanitizer to support the fight against coronavirus in New York and New Jersey. This might cause a significant decrease in the growth of the global DNA modifying enzyme market.
The research report on DNA Modifying Enzymes Market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on the market provides analysis and information according to market segments such as product type, applications, and end user.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
To know more about delivery timeline for this report Contact Sales
